Board of Directors

Sachiko Suzuki

Ms. Suzuki joined the UCSF Adult Hemophilia Treatment Center in 2016 as the 340B and Research Manager. She ensures the HTC is in compliance with 340B policies with a focus on sustainability in a rapidly changing 340B environment. She also helms the HTC’s research operations, which have grown to over 15 industry and government sponsored projects since 2017. With a background in research and the 340B program, Ms. Suzuki is especially interested in translational science and has been instrumental in the implementation of commercial gene therapy at UCSF.

Ms. Suzuki received her Masters in Public Health from San Francisco State University and has extensive experience in academic administration and research.